Status
Conditions
Treatments
About
This study is a prospective comparative study to gather pilot agreement and precision data in normal subjects, subjects with glaucoma, and subjects with retinal disease.
Enrollment
Sex
Ages
Volunteers
Inclusion and exclusion criteria
Inclusion Criteria (Normal Group):
Exclusion Criteria (Normal Group):
Inclusion Criteria (Glaucoma Group):
Subjects who have been diagnosed with glaucoma in the glaucoma study eye(s), with optic nerve damage as evidenced by either of the following optic disc or retinal nerve fiber layer structural abnormalities observed via fundus exam during the study visit:
Subjects with a current BSCVA of 20/40 or better in the glaucoma study eye(s) on the date of the visit; and
History of visual field defects within the previous two (2) months from the study visit or measured on the day of the study visit that is consistent with glaucomatous optic nerve damage based on at least one of the following findings:
Exclusion Criteria (Glaucoma Group):
Inclusion Criteria (Retinal Disease Group):
Exclusion Criteria (Retinal Disease Group):
Primary purpose
Allocation
Interventional model
Masking
12 participants in 1 patient group
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal